Answers are grounded in this paper and cite their sources.
Feasibility studies evaluate single-use technologies for scalable purification of lentiviral vectors, suggesting improved manufacturing solutions.
Watch the video or read the poster to learn:Why lentiviral vector production poses unique challengesHow technologies used in mAb production are being leveraged to provide scalable vector manufacturingOutcomes from a series of feasibility studies to evaluate single-use consumables for purification of lentiviral vectorsAbout the speakerTodd Sanderson has been with Pall since 2006. He has over 20 years of research experience with expertise in mammalian cell culture, process development and analytical method development. He currently leads the US team of Upstream and Analytics within the R&D Bioprocessing Group. He holds a B.S. in Biochemistry and B.S. in Psychology from Michigan State University. When not at work, Todd enjoys gardening and spending time with his young children
No takes yet. Share an insight, caveat, or question.
T. Sanderson (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: